Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending HubSpot HUBS Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 18 AnheuserBusch Inbev BUD Q1 2026 Earnings EPS Beats Estimates by 815 Amid Volume Recovery Knowles Q1 2026 Earnings EPS Beat Surprises Market Stock Slips 162 ICG Q4 2025 Earnings Massive EPS Miss Shakes Investor Confidence RNR Q1 2026 Earnings Strong Underwriting and Investment Results Drive EPS Beat